Laboratory diagnostics in acute poisoning: Critical overview

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 10, 2010, Pages 1381-1387

  Rentsch, Katharina M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

chromatography; immunoassay; mass spectrometry; poisoning

Indexed keywords

ALCOHOL; AMANITIN; AMPHETAMINE DERIVATIVE; ARSENIC; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID DERIVATIVE; COLCHICINE; CYANIDE; DIGOXIN; ETHYLENE GLYCOL; HYDROXYBUTYRIC ACID; IRON; LITHIUM; LYSERGIDE; MERCURY; METAL DERIVATIVE; METHADONE; METHANOL; OPIATE DERIVATIVE; PARACETAMOL; PHENCYCLIDINE; POISON; THALLIUM;

ANALYTIC METHOD; AUTOMATION; CLINICAL CHEMISTRY; DIODE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTOXICATION; LABORATORY DIAGNOSIS; MASS SPECTROMETER; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RELIABILITY; REVIEW; SCREENING TEST; TECHNOLOGY;

ACUTE DISEASE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; POISONING; SENSITIVITY AND SPECIFICITY;

EID: 77958160926     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.295     Document Type: Review

References (31)

1. Maurer HH, Kraemer T, Springer D, Staack RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther Drug Monit 2004;26:127-31.
2. Maurer HH. Systematic toxicological analysis of drugs and their metabolites by gas chromatography-mass spectrometry. J Chromatogr 1992;580:3-41.
3. Sauvage FL, Sain-Marcoux F, Duretz B, Deporte D, Lachatre G, Marquet P. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem 2006;52:1735-42.
4. Lee HK, Ho CS, Io YP, Lai PS, Shek CC, Lo AC, et al. Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-offlight mass spectrometry. Anal Chim Acta 2009;649:80-90.
5. Liu HC, Liu RH, Lin DL, Ho HO. Rapid screening and confirmation of drugs and toxic compounds in biological specimens using liquid chromatography/ion trap tandem mass spectrometry and automated library search. Rapid Commun Mass Spectrom 2010;24:75-84.
6. Dresen S, Ferreiros N, Gnann H, Zimmermann R, Weinmann W. Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP LC-MS/MS system and library searching. Anal Bioanal Chem 2010;396:2425-34.
7. Forrest IS, Forrest FM. Urine colour test for the detection of phenothiazine compounds. Clin Chem 1960;6:11-5.
8. Kraemer T, Paul LD. Bioanalytical procedures for determination of drugs of abuse in blood. Anal Bioanal Chem 2007;388:1415-35.
9. Rumack BH, Peterson RG. Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics 1978;62:898-903.
10. Slattery JT, Levy G. Acetaminophen kinetics in acutely poisoned patients. Clin Pharm Ther 1979;25:185-95.
11. Polson J, Wians FH Jr, Orsulak P, Fuller D, Murray NG, Koff JM, et al. False positive acetaminophen concentrations in patients with liver injury. Clin Chim Acta 2008;391:24-30.
12. Bertholf RL, Johannsen LM, Bazooband A, Mansouri V. Falsepositive acetaminophen results in a hyperbilirubinemic patient. Clin Chem 2003;49:695-8.
13. Dasgupta A. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin. Am J Clin Pathol 2002;118:132-40.
14. Maurer HH, Schmitt CJ, Weber AA, Kraemer T. Validated electrospray liquid chromatographic-mass spectrometric assay for the determination of the mushroom toxins alpha-and beta-amanitin in urine after immunoaffinity extraction. J Chromatogr B Biomed Sci Appl 2000;748:125-35.
15. Vesconi S, Langer M, Iapichino G, Costantino D, Busi C, Fiume L. Therapy of cytotoxic mushroom intoxication. Crit Care Med 1985;13:402-6.
16. Killander J, de la Torre R, Segura J, de Zeeuw R, Williams J. Recommendations for the reliable detection of illicit drugs in urine, with special attention to the workplace, in the European Union (December 1996). The Toxicology Experts' Working Group. Scand J Clin Lab Invest 1997;57:97-103.
17. Hsu J, Liu C, Liu CP, Tsay WI, Li JH, Lin DL, et al. Performance characteristics of selected immunoassays for preliminary test of 3, 4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens. J Anal Toxicol 2003;27:471-8.
18. Schutz H, Auch J, Erdmann F, Weiler G, Verhoff MA. Reliability of the cloned-enzyme donor immunoassay (CEDIA) for cocaine in human serum in the range between the detection limit and the cut-off. Arzneimittelforschung 2006;56:414-20.
19. Pragst F, Herzler M, Herre S, Erxleben B-T, Rothe M. UV spectra of toxic compound: database of photodiode array UV spectra of illegal and theraputic drugs, pesticides, ecotoxic substances and other poisons, 1st ed. Berlin: Verlag Toxicological Chemistry, 2008:408 pp.
20. Maurer HH, Pfleger K, Weber AA. Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites, 3rd ed. Weinheim: Wiley-VCH, 2007:1432 pp.
21. Jansen R, Lachatre G, Marquet P. LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings. Clin Biochem 2005;38:362-72.
22. Ojanpera S, Pelander A, Pelzing M, Krebs I, Vuori E, Ojanpera I. Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2006;20:1161-7.
23. Decaestecker TN, Vande Casteele SR, Wallemacq PE, van Peteghem CH, Defore DL, van Bocxlaer JF. Informationdependent acquisition-mediated LC-MS/MS screening procedure with semiquantitative potential. Anal Chem 2004;76:6365-73.
24. Dresen S, Gergov M, Politi L, Halter C, Weinmann W. ESI-MS/MS library of 1253 compounds for application in forensic and clinical toxicology. Anal Bioanal Chem 2009;395:2521-6.
25. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:2198-207.
26. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852:22-34.
27. Maurer HH, Kratzsch C, Kraemer T, Peters FT, Weber AA. Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002;773:63-73.
28. Sauvage FL, Gaulier JM, Lachatre G, Marquet P. Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clin Chem 2008;54:1519-27.
29. Kratzsch C, Weber AA, Peter FT, Kraemer T, Maurer HH. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. J Mass Spectrom 2003;38:283-95.
30. Louagie HK, Verstraete AG, De Soete CJ, Baetens D, Calle PA. A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol. Clin Toxicol 1997;35:591-4.
31. Vesey CJ, McAllister H, Langford RM. A simple, rapid and sensitive semimicro method for the measurement of cyanide in blood. Ann Clin Biochem 1999;36:755-8.